Search Results - "Stephan, J.L."

Refine Results
  1. 1

    24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk by Ma, Yuan, He, Feng J, Sun, Qi, Yuan, Changzheng, Kieneker, Lyanne M, Curhan, Gary C, MacGregor, Graham A, Bakker, Stephan J.L, Campbell, Norm R.C, Wang, Molin, Rimm, Eric B, Manson, JoAnn E, Willett, Walter C, Hofman, Albert, Gansevoort, Ron T, Cook, Nancy R, Hu, Frank B

    Published in The New England journal of medicine (20-01-2022)
    “…The relation between sodium intake and cardiovascular disease is controversial. This study used individual-participant data from six prospective cohorts of…”
    Get full text
    Journal Article
  2. 2

    Physical inactivity: a risk factor and target for intervention in renal care by Zelle, Dorien M., Klaassen, Gerald, van Adrichem, Edwin, Bakker, Stephan J.L., Corpeleijn, Eva, Navis, Gerjan

    Published in Nature reviews. Nephrology (01-03-2017)
    “…Key Points Physical inactivity is a major modifiable risk factor for poor health-related quality of life, morbidity and mortality in patients with renal…”
    Get full text
    Journal Article
  3. 3

    Concentration of Branched-Chain Amino Acids Is a Strong Risk Marker for Incident Hypertension by Flores-Guerrero, Jose L., Groothof, Dion, Connelly, Margery A., Otvos, James D., Bakker, Stephan J.L., Dullaart, Robin P.F.

    Published in Hypertension (Dallas, Tex. 1979) (01-12-2019)
    “…The potential role of branched-chain amino acids (BCAAs) in the pathogenesis of cardiometabolic diseases is increasingly recognized, but the association of…”
    Get full text
    Journal Article
  4. 4

    Circulating Total Bilirubin and Risk of Incident Cardiovascular Disease in the General Population by Kunutsor, Setor K, Bakker, Stephan J.L, Gansevoort, Ronald T, Chowdhury, Rajiv, Dullaart, Robin P.F

    “…OBJECTIVE—To assess the association of circulating total bilirubin and cardiovascular disease (CVD) risk in a new prospective study and to determine whether…”
    Get full text
    Journal Article
  5. 5

    Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies by Kunutsor, Setor K, Bakker, Stephan J.L, James, Richard W, Dullaart, Robin P.F

    Published in Atherosclerosis (01-02-2016)
    “…Abstract Background Paraoxonase-1 (PON-1) has been suggested to be associated with cardiovascular disease (CVD) risk, however, aspects of the association, such…”
    Get full text
    Journal Article
  6. 6

    Clinical Validation of Simultaneous Analysis of Tacrolimus, Cyclosporine A, and Creatinine in Dried Blood Spots in Kidney Transplant Patients by Veenhof, Herman, Koster, Remco A, Alffenaar, Jan-Willem C, Berger, Stefan P, Bakker, Stephan J.L, Touw, Daan J

    Published in Transplantation (01-07-2017)
    “…BACKGROUNDMonitoring of creatinine and immunosuppressive drug concentrations, such as tacrolimus (TaC) and cyclosporin A (CsA), is important in the outpatient…”
    Get full text
    Journal Article
  7. 7
  8. 8

    HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population: A Case-Control Study From the PREVEND Cohort by Ebtehaj, Sanam, Gruppen, Eke G, Bakker, Stephan J.L, Dullaart, Robin P.F, Tietge, Uwe J.F

    “…OBJECTIVE:Focus is shifting from HDL-C (high-density lipoprotein cholesterol) as predictive biomarker for cardiovascular disease (CVD) towards antiatherogenic…”
    Get full text
    Journal Article
  9. 9

    High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events by Jia, Congzhuo, Anderson, Josephine L.C., Gruppen, Eke G., Lei, Yu, Bakker, Stephan J.L., Dullaart, Robin P.F., Tietge, Uwe J.F.

    Published in Circulation (New York, N.Y.) (18-05-2021)
    “…The role of high-density lipoprotein (HDL) function in cardiovascular disease represents an important emerging concept. The present study investigated whether…”
    Get full text
    Journal Article
  10. 10

    Phosphate and fibroblast growth factor 23 in diabetes by van der Vaart, Amarens, Yeung, Stanley M H, van Dijk, Peter R, Bakker, Stephan J L, de Borst, Martin H

    Published in Clinical science (1979) (01-07-2021)
    “…Diabetes is associated with a strongly elevated risk of cardiovascular disease, which is even more pronounced in patients with diabetic nephropathy. Currently…”
    Get more information
    Journal Article
  11. 11

    Creatine is a Conditionally Essential Nutrient in Chronic Kidney Disease: A Hypothesis and Narrative Literature Review by Post, Adrian, Tsikas, Dimitrios, Bakker, Stephan J L

    Published in Nutrients (10-05-2019)
    “…To accommodate the loss of the plethora of functions of the kidneys, patients with chronic kidney disease require many dietary adjustments, including…”
    Get full text
    Journal Article
  12. 12
  13. 13

    HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study by Sokooti, Sara, Flores-Guerrero, Jose L, Kieneker, Lyanne M, Heerspink, Hiddo J L, Connelly, Margery A, Bakker, Stephan J L, Dullaart, Robin P F

    “…ContextHigh-density lipoproteins (HDL) may be protective against type 2 diabetes (T2D) development, but HDL particles vary in size and function, which could…”
    Get full text
    Journal Article
  14. 14

    Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study by Kunutsor, Setor K, Bakker, Stephan J.L, Kootstra-Ros, Jenny E, Blokzijl, Hans, Gansevoort, Ronald T, Dullaart, Robin P.F

    Published in Atherosclerosis (01-11-2015)
    “…Abstract Background Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) have been linked with an increased risk of type 2 diabetes, but their…”
    Get full text
    Journal Article
  15. 15

    Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population by Oterdoom, Leendert H, Gansevoort, Ron T, Schouten, Jan P, de Jong, Paul E, Gans, Reinold O.B, Bakker, Stephan J.L

    Published in Atherosclerosis (01-12-2009)
    “…Abstract Objective Low muscle mass often indicates poor health, but the relation with cardiovascular disease (CVD) is unknown. Skeletal muscles are responsible…”
    Get full text
    Journal Article
  16. 16

    Effects of Education and Income on Incident Type 2 Diabetes and Cardiovascular Diseases: a Dutch Prospective Study by Duan, Ming-Jie F., Zhu, Yinjie, Dekker, Louise H., Mierau, Jochen O., Corpeleijn, Eva, Bakker, Stephan J.L., Navis, Gerjan

    “…Background Education and income, as two primary socioeconomic indicators, are often used interchangeably in health research. However, there is a lack of clear…”
    Get full text
    Journal Article
  17. 17

    Calcification Propensity and Survival among Renal Transplant Recipients by Keyzer, Charlotte A, de Borst, Martin H, van den Berg, Else, Jahnen-Dechent, Willi, Arampatzis, Spyridon, Farese, Stefan, Bergmann, Ivo P, Floege, Jürgen, Navis, Gerjan, Bakker, Stephan J L, van Goor, Harry, Eisenberger, Ute, Pasch, Andreas

    “…Calciprotein particle maturation time (T50) in serum is a novel measure of individual blood calcification propensity. To determine the clinical relevance of…”
    Get full text
    Journal Article
  18. 18

    Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes by Nauta, Ferdau L, Boertien, Wendy E, Bakker, Stephan J.L, van Goor, Harry, van Oeveren, Wim, de Jong, Paul E, Bilo, Henk, Gansevoort, Ron T

    Published in Diabetes care (01-04-2011)
    “…OBJECTIVE: We investigated in a cross-sectional study the levels of serum and urinary damage markers in diabetic patients (n = 94) and nondiabetic control…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes by Borderie, Gauthier, Schnebelen, Marie, Baynat, Louise, Groothof, Dion, Vogelpohl, Fabian A, Bakker, Stephan J.L, He, Liyun, Zhang, Huabing, Gerstein, Hertzel C, Khurmi, Nardev S

    Published in The New England journal of medicine (25-11-2021)
    “…To the Editor: In the AMPLITUDE-O trial, Gerstein et al. (Sept. 2 issue) 1 found a lower risk of cardiovascular events among participants with type 2 diabetes…”
    Get full text
    Journal Article